Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database

Validation of Acute Myocardial Infarction Cases in the National Health Insurance Research Database in Taiwan

(2014) Ching-Lan Cheng et al.   JOURNAL OF EPIDEMIOLOGY

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis

(2013) E. P. Navarese et al.   BMJ-British Medical Journal

Safety and efficacy of everolimus- versus sirolimus-eluting stents: A systematic review and meta-analysis of 11 randomized trials

(2012) Kyung Woo Park et al.   AMERICAN HEART JOURNAL

Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

(2012) Takeshi Kimura et al.   CIRCULATION

Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention

(2012) Lisette Okkels Jensen et al.   CIRCULATION

3-Year Clinical Outcomes in the Randomized SORT OUT III Superiority Trial Comparing Zotarolimus- and Sirolimus-Eluting Coronary Stents

(2012) Michael Maeng et al.   JACC-Cardiovascular Interventions

Second-Generation Everolimus-Eluting Stents Versus First-Generation Sirolimus-Eluting Stents in Acute Myocardial Infarction

(2012) Sjoerd H. Hofma et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2-Year Patient-Related Versus Stent-Related Outcomes

(2012) Lisette Okkels Jensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial

(2012) Edoardo Camenzind et al.   LANCET

Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials

(2011) Salvatore Cassese et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention

(2011) Kyung Woo Park et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease

(2010) Cihan Simsek et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions

(2010) Martin B. Leon et al.   JACC-Cardiovascular Interventions

Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization

(2010) Duk-Woo Park et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Stents

(2010) Scot Garg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2010 Guidelines of the Taiwan Society of Cardiology for the Management of Hypertension

(2010) Chern-En Chiang et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

(2010) Klaus Rasmussen et al.   LANCET

Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents

(2009) Gregg W. Stone et al.   CIRCULATION

2-Year Clinical Outcomes After Implantation of Sirolimus-Eluting, Paclitaxel-Eluting, and Bare-Metal Coronary Stents

(2009) Anne Kaltoft et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation

(2009) Adriano Caixeta et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

(2008) Michael Joner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY